FDA grants approval for generic version of antipsychotic drug Abilify

The US Food and Drug Administration (FDA) has granted approval for the first generic versions of Abilify (aripiprazole), which is an atypical antipsychotic drug to treat schizophrenia and bipolar disorder.
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news